You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 17, 2024

Claims for Patent: 5,407,814


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,407,814
Title: Genetic fingerprinting of yeasts
Abstract:The present invention relates to the identification of yeast strains by way of application of the polymerase chain reaction to amplify nucleic acid sequences characteristic of their TY transposon long terminal repeats. Polymerase chain reaction product is analysed, conveniently by agarose gel electrophoresis, and its nature related to the presence of a particular yeast strain or strain type.
Inventor(s): Pearson; Bruce M. (Norwich, GB), Carter; Andrew T. (Norwich, GB), McKee; Raymond A. (Norwich, GB)
Assignee: The Secretary of State for the Minister of Agriculture, Fisheries & Food Britain and Northern Ireland (London, GB)
Application Number:07/855,759
Patent Claims:1. A method for characterizing a yeast as being of a particular strain or strain type comprising:

(a) amplifying a nucleic acids in a sample consisting essentially of yeast nucleic acid using a polymerase chain reaction comprising deoxynucleotide triphosphates, polymera a reaction template and at least one, primer, wherein said yeast nucleic acid is said reaction template and said at least one primer comprises one or more oligonucleotide primers which hybridize to regions of nucleic acid of yeast TY transposon long terminal repeats and

(b) analyzing the reaction product from (a), comparing the analysis with reaction products of particular yeast strains or strain types,

wherein the nucleic acid to which the primers hybridize is selected from the group consisting of regions represented by SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO: 5 and SEQ ID NO: 6.

2. The method as claimed in claim 1 wherein the primers are selected from the group consisting of primers represented by SEQ ID NO:3, SEQ ID NO: 4, SEQ ID NO: 7, and SEQ ID NO:8.

3. The method as claimed in claim 1 further comprising amplifying with four or more primers such that two of said primers hybridize with each of the TY transposon long terminal repeats.

4. The method as claimed in claim 1 further comprising amplifying with one or more oligonucleotide primers complementary to yeast genome sequences.

5. The method as claimed in claim 1 wherein said sample contains sterile water.

6. The method as claimed in any one of claims 1 to 3 wherein said amplifying further comprises contacting and mixing said sample in polymerase chain reaction components to produce a mixture, covering said mixture with a sterile oil overlay to form a treated sample, and then subjecting treated sample to cycles of temperature suitable for denaturing duplexes, for annealing of primers and for primer extension such that oligonucleotide fragments are produced.

7. The method as claimed in any one of claims 1 to 3 wherein said amplifying further comprises temperature cycles comprising primer annealing periods at from 45.degree. C. to 62.degree. C.

8. The method as claimed in claim 7 wherein the primer annealing period temperature is from 50.degree. C. to 55.degree. C.

9. A kit for the characterization of yeast strains by the method of claim 1 comprising one or more oligonucleotide polymerase chain reaction primers comprising nucleotide sequences which are fully complementary to any one of the nucleic acid sequences of yeast TY transposon long terminal repeats represented by SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:5 and SEQ ID No:6.

10. The kit as claimed in claim 9 wherein the oligonucleotide primers comprise one pair of primers which hybridize to the double stranded nucleic acid sequence represented by SEQ ID NO:1 or SEQ ID NO:2.

11. The kit as claimed in claim 9 wherein the oligonucleotide primers comprise one pair of primers which hybridize to the double stranded nucleic acid sequence represented by SEQ ID NO:5 and SEQ ID NO:6.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.